By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo

TheMediTary.Com

Medical Information, Documents, News - TheMediTary.Com

  • Home
  • News
  • Drugs
  • Drugs A-Z
  • Medical Answers
  • About Us
  • Contact
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo
Search Drugs
  • Drugs
    • Latest Drugs
    • Drugs A-Z
    • Medical Answers
  • News
    • FDA Alerts
    • Medical News
    • Health
    • Consumer Updates
    • Children's Health
  • More TheMediTary.Com
    • About Us
    • Contact
Follow US
Home > Drugs > Interleukin inhibitors > Basiliximab > Basiliximab Dosage
Interleukin inhibitors
https://themeditary.com/dosage-information/basiliximab-dosage-10784.html

Basiliximab Dosage

Drug Detail:Basiliximab (Basiliximab [ bass-il-ix-im-ab ])

Drug Class: Interleukin inhibitors

Contents
Uses Warnings Before Taking Dosage Side effects Interactions

Usual Adult Dose for Organ Transplant - Rejection Prophylaxis

20 mg by IV infusion over 20 to 30 minutes or by IV bolus injection within 2 hours before surgery and 4 days after transplantation; withhold the second dose if complications occur (e.g., severe hypersensitivity or graft loss)

Comments:

  • This drug is used as part of an immunosuppressive regimen that includes cyclosporine and corticosteroids.

Use: For the prophylaxis of acute organ rejection in patients receiving renal transplantation when used as part of an immunosuppressive regimen that includes cyclosporine and corticosteroids

Usual Pediatric Dose for Organ Transplant - Rejection Prophylaxis

One year and older:

  • Weight 35 kg or less: 10 mg by IV infusion over 20 to 30 minutes or by IV bolus injection within 2 hours before surgery and 4 days after transplantation; withhold the second dose if complications occur (e.g., severe hypersensitivity or graft loss)
  • Weight 35 kg or more: 20 mg by IV infusion over 20 to 30 minutes or by IV bolus injection within 2 hours before surgery and 4 days after transplantation; withhold the second dose if complications occur (e.g., severe hypersensitivity or graft loss)

Comments:
  • This drug is used as part of an immunosuppressive regimen that includes cyclosporine and corticosteroids.

Use: For the prophylaxis of acute organ rejection in patients receiving renal transplantation when used as part of an immunosuppressive regimen that includes cyclosporine and corticosteroids

Renal Dose Adjustments

Data not available

Liver Dose Adjustments

Data not available

Precautions

US BOXED WARNINGS:

  • Only physicians experienced in immunosuppression therapy and management of organ transplantation patients should prescribe this drug.
  • The physician should have complete information for the follow-up of the patient.
  • Patients receiving the drug should be managed in facilities equipped and staffed with laboratory and supportive medical resources.

Safety and efficacy have not been established in patients younger than 1 year.

Consult WARNINGS section for additional precautions.

Dialysis

Data not available

Other Comments

Administration advice:

  • This drug is for central or peripheral IV administration only.
  • The reconstituted product should be given either as a bolus injection or diluted and administered as an IV over 20 to 30 minutes.
  • Bolus administration may be associated with nausea, vomiting, and local reactions (e.g., pain).
  • This drug should only be administered once it has been determined that the patient will receive the graft and concomitant immunosuppression.
  • Patients who previously received this drug should only be re-exposed with extreme caution due to the potential risk of hypersensitivity.

Storage requirements:
  • After reconstitution, the solution should be used immediately. If not used immediately, it can be stored at 2C to 8C for 24 hours or at room temperature for 4 hours.
  • Discard the reconstituted solution if not used within 24 hours.

Reconstitution/preparation techniques:
  • The reconstituted product should be inspected visually for particulate matter and discoloration before administration; after reconstitution, it should be a clear-to-opalescent, colorless solution. Do not use if particulate matter is present or the solution is colored.

IV compatibility:
  • No incompatibility between this drug and polyvinyl chloride bags or infusion sets has been observed. No data are available on the compatibility of this drug with other IV substances. Other drug substances should not be added or infused simultaneously through the same IV line.

General:
  • The product does not contain any antimicrobial preservatives or bacteriostatic agents.
Share this Article
Latest News
Medical News

Shingles vaccine may lower heart disease risk by up to 8 years

May 09, 2025
Obesity, unhealthy lifestyles may cause heart to age by 5–45 years
Aging: As little as 5 minutes of exercise may keep the brain healthy
Prostate cancer: Simple urine test may help with early detection
Cancer treatment side effects: Exercise may reduce pain, fatigue
Alzheimer's: Exercising in middle age may reduce beta-amyloid in brain...
Related Drugs
Fidanacogene Elaparvovec
Cerave Anti-Itch
Centrum Adult
Crovalimab
Cyltezo Prefilled Syringe
Zepbound Pen
Mylanta One
Uretron Ds
Medihoney Wound And Burn Dressing
Lidotrode

Other drugs

Name Drug Class Updated
Fidanacogene Elaparvovec Drugs 03-Oct-2024
Cerave Anti-Itch Drugs 02-Oct-2024
Centrum Adult Drugs 02-Oct-2024
Crovalimab Drugs 02-Oct-2024
Cyltezo Prefilled Syringe Drugs 01-Oct-2024
Zepbound Pen Drugs 30-Sep-2024
Mylanta One Drugs 27-Sep-2024
Uretron Ds Drugs 27-Sep-2024
Medihoney Wound And Burn Dressing Drugs 26-Sep-2024
Lidotrode Drugs 26-Sep-2024
Libervant Drugs 26-Sep-2024
Moderna Covid-19 Drugs 25-Sep-2024
Beqvez Drugs 24-Sep-2024
Beqvez Drugs 24-Sep-2024
Beqvez Drugs 24-Sep-2024

Categories

  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health

About US

Welcome to TheMediTary.Com

Our website provides reliable and up-to-date information on various medical topics. We empower individuals to take charge of their health by simplifying complex medical jargon and providing practical tips and advice. We prioritize the privacy and confidentiality of our users and welcome feedback to improve our services.

Website use data of FDA and other sources

DMCA.com Protection Status Truste Protection Status Trust Mark Protection Status
HONcode logo We comply with the HONcode standard for trustworthy health information.
Quick Link
  • About Us
  • Contact Us
  • Editorial Policy
  • Privacy Policy
  • Accessibility Policy
  • Terms & Conditions
  • Disclaimer
  • DMCA
  • Do Not Sell My Personal Information
  • Sitemap
  • Care Notes
  • Health Guide
  • Professional
Drugs
  • New Drugs
  • Medical Answers
  • Drugs A-Z
  • Drug Classes
  • Drug Dosage
  • Pill Identifier
  • Consumer Infor
  • Side Effects
  • Inactive Ingredients
  • Pregnancy Warnings
  • Patient Tips
  • Treatments
News
  • Latest News
  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health
Find US
  • Medium
  • Google Site
  • Blogspot
  • API
  • Reddit
  • Tumblr
  • Scoop.it
  • Substack
  • Wordpress
  • Wix
  • Behance

© 2025 TheMediTary.Com All rights reserved. Operated by